Skip to content

Clinical trials

Completed Phase 3 Muscular Dystrophy, Duchenne trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20102
20122
20133
20141
20151
20161
20172
20182
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics3
Sarepta Therapeutics, Inc.3
National Center for Research Resources (NCRR)2
Novartis Pharmaceuticals2
University Hospital, Basel, Switzerland2
Assistance Publique - Hôpitaux de Paris1
Catabasis Pharmaceuticals1
Cooperative International Neuromuscular Research Group1
GlaxoSmithKline1
Italfarmaco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne22
Muscular Dystrophies8
Neuromuscular Diseases4
Genetic Diseases, Inborn3
Musculoskeletal Diseases3
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Nervous System Diseases2
Osteoporosis2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.